Key facts
- RTW INVESTMENTS, LP filed SCHEDULE 13D/A for Avidity Biosciences, Inc. Common Stock, par value $0.0001 per share (RNA).
- Disclosed ownership: 3.1%.
- Date of event: 27 Oct 2025.
RTW INVESTMENTS, LP - 27 Oct 2025 SCHEDULE 13D/A Report for Avidity Biosciences, Inc. Common Stock, par value $0.0001 per share (RNA)
- Filing Manager
- RTW INVESTMENTS, LP
- Reporting Manager
- RTW Investments, LP
- Symbol
- RNA
- Shares outstanding
- 151,164,839 shares
- Disclosed Ownership
- 4,686,110 shares
- Ownership
- 3.1%
- Form type
- SCHEDULE 13D/A
- Filing time
- 29 Oct 2025, 21:14:09 UTC
- Date of event
- 27 Oct 2025
- SEC
- View on sec.gov
Key filing fact
RTW INVESTMENTS, LP disclosed 3.1% ownership in Avidity Biosciences, Inc. Common Stock, par value $0.0001 per share (RNA) on 27 Oct 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 29 Oct 2025, 21:14.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (2)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RTW Investments, LP | 3.1% | 4,686,110 | 0 | 4,686,110 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D., Managing Partner | 0001493215 |
| Roderick Wong | 3.1% | 4,686,110 | 0 | 4,686,110 | /s/ Roderick Wong, M.D. | Roderick Wong, M.D. | 0001493280 |
CIK / CUSIP context first